Pliant Therapeutics, Inc. Common Stock
$1.13
-$0.00 (-0.44%)
$1.10Day Range$1.13
Key Statistics
Market Cap
$69.97M
Shares Outstanding
61.9M
Primary Exchange
XNAS
Currency
USD
Type
CS
IPO Date
Jun 3, 2020
Round Lot
100
Locale
US
Trading Data
Day Open
$1.13
Day High
$1.13
Day Low
$1.10
Volume
117.1K
VWAP
$1.11
Prev Close
$1.13
Transactions
--
Acc. Volume
--
About Pliant Therapeutics, Inc. Common Stock
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
PHARMACEUTICAL PREPARATIONSSIC 283449 employees331 OYSTER POINT BOULEVARD, SOUTH SAN FRANCISCO, CA, 94080650-481-6770IPO Jun 3, 2020US / STOCKSActiveWebsite
Identifiers
- CIK
- 0001746473
- Composite FIGI
- BBG00C8083N4
- Share Class FIGI
- BBG00C8083P2
- Ticker Root
- PLRX
- SIC Code
- 2834
About Pliant Therapeutics, Inc. Common Stock (PLRX) Stock
Pliant Therapeutics, Inc. Common Stock (PLRX) closed the 2026-09-18 session at $1.13, down 0.44% versus the previous close (-0.00). The stock opened at $1.13 and traded between $1.10 and $1.13 during that session. Session trading volume was 117K shares. The volume-weighted average price (VWAP) is $1.11.
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Pliant Therapeutics, Inc. Common Stock has a market capitalization of $70.0 million. The company operates in the PHARMACEUTICAL PREPARATIONS industry classification. PLRX is listed on the XNAS exchange. The company employs approximately 49 people. Pliant Therapeutics, Inc. Common Stock is headquartered in SOUTH SAN FRANCISCO, CA. The recorded listing date is 2020-06-03.
On this page you can find market PLRX stock price data, interactive price charts with multiple timeframes (1 day to max history), company financials including income statements, balance sheets, and cash flow statements, technical indicators (SMA 50, SMA 200, EMA 20, MACD, RSI), latest news and sentiment analysis, dividend history, stock splits, short interest data, float information, and related stocks.
Explore more: View today's market movers, use the stock screener, or browse all sectors. See more stocks in the PHARMACEUTICAL PREPARATIONS sector.